Huntington's Disease is a disorder of the corpus striatum: Focus on Rhes (Ras homologue enriched in the striatum)

Srinivasa Subramaniam, Solomon H. Snyder

Research output: Contribution to journalReview article

Abstract

Despite identification of the gene for huntingtin (Htt) as causal in Huntington's Disease (HD), explication of HD symptoms and selective damage to the corpus striatum has been elusive. The small G protein Rhes Ras homolog enriched in striatum, highly localized to the striatum, binds selectively to mutant Htt (mHtt) and enhances sumoylation of mHtt. Sumoylation disaggregates mHtt and augments its cytotoxicity. Thus, it appears likely that Rhes-mHtt interaction accounts in substantial part for the selective striatal neurotoxicity of HD with associated extrapyramidal symptomatology. Rhes also binds and activates mTOR, enhancing its influence on protein synthesis, and may be the principal determinant of striatal mTOR activation. In HD, sequestration of Rhes by mHtt may decrease its access to mTOR. The attendant loss of protein translational stimulation may explain the pronounced striatal atrophy of HD. This article is part of a Special Issue entitled 'Trends in Neuropharmacology: In Memory of Erminio Costa'.

Original languageEnglish (US)
Pages (from-to)1187-1192
Number of pages6
JournalNeuropharmacology
Volume60
Issue number7-8
DOIs
StatePublished - Jun 1 2011

Keywords

  • Atrophy
  • HAP
  • HIP
  • Huntington Disease
  • Rhes
  • Striatum
  • mTOR
  • mutant Huntingtin

ASJC Scopus subject areas

  • Pharmacology
  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of 'Huntington's Disease is a disorder of the corpus striatum: Focus on Rhes (Ras homologue enriched in the striatum)'. Together they form a unique fingerprint.

  • Cite this